Increasing Sodium-Glucose Cotransporter 2 Inhibitor Use in CKD: Perspectives and Presentation of a Clinical Pathway

Detalles Bibliográficos
Autores principales: Nishi, Laura, Ghossein, Cybele, Srivastava, Anand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052139/
https://www.ncbi.nlm.nih.gov/pubmed/35498158
http://dx.doi.org/10.1016/j.xkme.2022.100446
_version_ 1784696721082679296
author Nishi, Laura
Ghossein, Cybele
Srivastava, Anand
author_facet Nishi, Laura
Ghossein, Cybele
Srivastava, Anand
author_sort Nishi, Laura
collection PubMed
description
format Online
Article
Text
id pubmed-9052139
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90521392022-04-30 Increasing Sodium-Glucose Cotransporter 2 Inhibitor Use in CKD: Perspectives and Presentation of a Clinical Pathway Nishi, Laura Ghossein, Cybele Srivastava, Anand Kidney Med Editorial Elsevier 2022-03-12 /pmc/articles/PMC9052139/ /pubmed/35498158 http://dx.doi.org/10.1016/j.xkme.2022.100446 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial
Nishi, Laura
Ghossein, Cybele
Srivastava, Anand
Increasing Sodium-Glucose Cotransporter 2 Inhibitor Use in CKD: Perspectives and Presentation of a Clinical Pathway
title Increasing Sodium-Glucose Cotransporter 2 Inhibitor Use in CKD: Perspectives and Presentation of a Clinical Pathway
title_full Increasing Sodium-Glucose Cotransporter 2 Inhibitor Use in CKD: Perspectives and Presentation of a Clinical Pathway
title_fullStr Increasing Sodium-Glucose Cotransporter 2 Inhibitor Use in CKD: Perspectives and Presentation of a Clinical Pathway
title_full_unstemmed Increasing Sodium-Glucose Cotransporter 2 Inhibitor Use in CKD: Perspectives and Presentation of a Clinical Pathway
title_short Increasing Sodium-Glucose Cotransporter 2 Inhibitor Use in CKD: Perspectives and Presentation of a Clinical Pathway
title_sort increasing sodium-glucose cotransporter 2 inhibitor use in ckd: perspectives and presentation of a clinical pathway
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052139/
https://www.ncbi.nlm.nih.gov/pubmed/35498158
http://dx.doi.org/10.1016/j.xkme.2022.100446
work_keys_str_mv AT nishilaura increasingsodiumglucosecotransporter2inhibitoruseinckdperspectivesandpresentationofaclinicalpathway
AT ghosseincybele increasingsodiumglucosecotransporter2inhibitoruseinckdperspectivesandpresentationofaclinicalpathway
AT srivastavaanand increasingsodiumglucosecotransporter2inhibitoruseinckdperspectivesandpresentationofaclinicalpathway

Ejemplares similares